Strand Therapeutics

Drug DiscoveryWebsite
Current Valuation
$571.0M
As of August 7, 2025
Total Funding Raised
$255.6M
Across 1 round
Last Round
Later Stage VC

$153.0M

Last Funding
Aug 2025

Funding date

Capital Efficiency
2.23x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
August 7, 2025Later Stage VC (Series B)$153.0MN/A-
Valuation Analysis

Current Valuation Metrics

Strand Therapeutics is currently valued at $571.0M as of August 7, 2025. The company has raised a total of $255.6M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 2.23x, Strand Therapeutics has achieved a valuation that is 2.23 times the total capital raised.

Track Strand Therapeutics Valuation Updates

Get notified when Strand Therapeutics raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Strand Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Strand Therapeutics Worth in 2026?

Strand Therapeutics is a leading private company in the Drug Discovery sector. Track Strand Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Strand Therapeutics Valuation is Determined

Private company valuations like Strand Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.